Mitoquinone alleviates osteoarthritis progress by activating the NRF2-Parkin axis
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 48 references indexed in Scilit:
- Osteoarthritis year 2012 in review: biomarkersOsteoarthritis and Cartilage, 2012
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Mitochondria: In Sickness and in HealthCell, 2012
- A role for mitochondria in NLRP3 inflammasome activationNature, 2010
- The role of synovitis in pathophysiology and clinical symptoms of osteoarthritisNature Reviews Rheumatology, 2010
- The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouseOsteoarthritis and Cartilage, 2010
- A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's diseaseMovement Disorders, 2010
- Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type miceFree Radical Biology and Medicine, 2010
- Mitochondria-Targeted Antioxidant MitoQ 10 Improves Endothelial Function and Attenuates Cardiac HypertrophyHypertension, 2009
- Osteoarthritis severity is sex dependent in a surgical mouse modelOsteoarthritis and Cartilage, 2007